Please login to the form below

Not currently logged in
Email:
Password:
I have forgotten my password

Dr Reddy's

This page shows the latest Dr Reddy's news and features for those working in and with pharma, biotech and healthcare.

Amarin shares tumble following Vascepa patent loss

Amarin shares tumble following Vascepa patent loss

Dr Reddy’s Laboratories and Hikma Pharmaceuticals are already queueing up to launch generic versions of Vascepa, with Hikma reporting that it is working with the FDA to gain approval for ... The patent ruling only applies to Vascepa’s US patent

Latest news

More from news
Approximately 3 fully matching, plus 54 partially matching documents found.

Latest Intelligence

  • Deal Watch September 2016 Deal Watch September 2016

    Dr Reddy's has expanded its collaboration with Amgen in India adding three approved products: Xgeva for treating bone metastases, Vectibix in colorectal cancer therapy and Prolia for osteoporosis. ... Upfront $80m plus $830m in milestones [ex S. Korea].

  • Deal Watch June 2016 Deal Watch June 2016

    The three deals with Mayne Pharma, Impax Laboratories and Dr Reddy's, for a combined value of over $1.5bn, cover portfolios of marketed and approved generic drugs, drugs currently pending ... acquisition assets/ return of rights. 586. Teva and Allergan/

  • Deal Watch March 2016 Deal Watch March 2016

    Two deals involved products at a later stage of development: Dr Reddy's licence for Xenoport's phase II product XP23829 for plaque psoriasis, and Ipsen's licence for Exelixis's ... Collaboration – development. $595. Xenoport/ Dr Reddy's. XP-23829 for

  • Medius Deal Watch table for April 2015 Medius Deal Watch table for April 2015

    The top major pharma mergers, acquisitions and collaborations during the month continued pharma's love affair with oncology. ... 151. UCB/ Dr. Reddy's. Business acquisition. Dermatology, respiratory and paediatric products for South Asia.

  • Pharma deals in April 2015 Pharma deals in April 2015

    Dr Reddy's, Menarini and Cipher Pharmaceuticals have acquired or licensed rights to products in South Asia, Asia Pacific (ex-Japan) and North America and Mexico, respectively. ... Previously rumoured, Dr Reddy's acquires rights to dermatology,

More from intelligence
Approximately 0 fully matching, plus 9 partially matching documents found.

Latest appointments

  • Dr Reddy's makes senior changes as US generics head exits Dr Reddy's makes senior changes as US generics head exits

    UmangVohra will be replaced by Alok Sonig. Dr Reddy's has appointed Alok Sonig to be its new head of North America generics to take over from Umang Vohra (pictured). ... Vohra's replacement at Dr Reddy's is the company's head of India generics Alok Sonig

  • MedImmune appoints Dr Anand Subramony MedImmune appoints Dr Anand Subramony

    While at Novartis Dr Subramony established and headed company's novel delivery technologies and therapeutics group. ... Prior to that he held leadership positions at Dr. Reddy's Laboratories in Bridgewater, New Jersey and Johnson &Johnson/Alza

  • Pegasus recruits corporate services lead Pegasus recruits corporate services lead

    His team's first priority, Mackenzie-Reid added, was to ensure the market understands Pegasus'new proposition. ... Clients include Bayer, Novo Nordisk, Fittleworth, Dr Reddy's and Holland &Barrett.

  • New global head of HR for Dr Reddy’s New global head of HR for Dr Reddy’s

    Sripada Chandrasekhar joins from IBM. Hyderabad, India-headquartered Dr Reddy's Laboratories has appointed a former IBM executive president and global head of human resources. ... Chakraborty remains with Dr Reddy's, and has retained all but the HR

  • Dr Reddy’s appoints Umang Vohra to lead US business Dr Reddy’s appoints Umang Vohra to lead US business

    Will be replaced as chief financial officer by Saumen Chakraborty. Indian generics company Dr Reddy's Laboratories has appointed Umang Vohra as the new head of its North American business. ... He first joined the company in 2002, moving from Pepsico-India

More from appointments
Approximately 2 fully matching, plus 3 partially matching documents found.

Subscribe to our email news alerts

PMHub

Add my company
Innovative Trials

Innovative Trials is a leading global clinical trial patient recruitment company. With over 10 years’ experience, Innovative Trials deploys “boots-on-the-ground”...

Latest intelligence

Virtual Patient Engagement Program: A Customer Story
Our client wanted to better understand the needs, preferences, and treatment gaps among adult patients with a rare genetic disease......
Humancomms for humancare?
Paul Hutchings, founder of fox&cat, writes on the role of humour in healthcare comms: PharmaComms 2023...
Rare diseases: not so rare after all
The brave new world addressing rare diseases – a way ahead to better and more inclusive treatment...

Quick links